Atypical Presentation of Post-Kala-Azar Dermal Leishmaniasis in Bhutan.
Journal
Case reports in dermatological medicine
ISSN: 2090-6463
Titre abrégé: Case Rep Dermatol Med
Pays: United States
ID NLM: 101591808
Informations de publication
Date de publication:
2020
2020
Historique:
received:
04
05
2020
revised:
01
08
2020
accepted:
14
08
2020
entrez:
9
9
2020
pubmed:
10
9
2020
medline:
10
9
2020
Statut:
epublish
Résumé
This article describes an atypical case of post-kala-azar dermal leishmaniasis associated with complications due to delayed diagnosis and poor case management. The grave consequences of the prolonged disease process that continued for over 2 decades with eventual healing included facial disfigurement, visual impairment, and mental distress both to the patient and the family. The persistent infection within the skin over a lengthy period with likely increased risk of infection spread in the community highlights its potential negative impact on the ongoing leishmaniasis elimination program in the Indian subcontinent. Bhutan is a member of the leishmaniasis elimination network in Asia, and the government continues to invest in maintenance of the national healthcare system. The case study reveals the gaps in the healthcare system with hardships faced by a patient to access quality healthcare and poor patient outcome used as proxy indicators. It also points to the need to enhance access to healthcare to ensure early diagnosis and effective treatment for leishmaniasis patients including those who live in remote areas, in order to achieve the planned disease elimination targets. It also points towards the key challenges faced by a resource poor nation such as Bhutan in achieving universal health coverage and reaching the set goals for disease elimination. The findings underscore the need for a careful review of the national health care system and to address the deficiencies.
Identifiants
pubmed: 32904486
doi: 10.1155/2020/8899586
pmc: PMC7456484
doi:
Types de publication
Case Reports
Langues
eng
Pagination
8899586Subventions
Organisme : NIAID NIH HHS
ID : U01 AI136033
Pays : United States
Informations de copyright
Copyright © 2020 Ambika Pradhan et al.
Déclaration de conflit d'intérêts
The authors declare that they have no conflicts of interest.
Références
Indian J Med Res. 2010 Sep;132:337-8
pubmed: 20847382
Parasitol Res. 2013 Mar;112(3):1001-9
pubmed: 23242321
Indian J Dermatol Venereol Leprol. 2004 Sep-Oct;70(5):280-2
pubmed: 17642637
PLoS Negl Trop Dis. 2011 Dec;5(12):e1433
pubmed: 22206030
Trop Doct. 2011 Jul;41(3):139-40
pubmed: 21676981
Clin Infect Dis. 2017 Jul 1;65(1):150-153
pubmed: 28520851
BMC Public Health. 2015 Oct 26;15:1092
pubmed: 26503551
Br J Dermatol. 2000 Jul;143(1):136-43
pubmed: 10886148
J Health Popul Nutr. 2013 Jun;31(2):294-7
pubmed: 23930349
Front Cell Infect Microbiol. 2019 Jul 31;9:228
pubmed: 31417876
PLoS Negl Trop Dis. 2017 Nov 16;11(11):e0005877
pubmed: 29145397
PLoS Negl Trop Dis. 2016 Oct 24;10(10):e0005060
pubmed: 27776123
Am J Trop Med Hyg. 2012 Dec;87(6):1028-37
pubmed: 23091191